CRG, a healthcare-focused investment firm, has promoted Scott Li to managing director and Zain Shekhani and Kevin Reilly to vice president. The appointments become effective immediately.
BOULDER, Colo., Aug. 13, 2018 /PRNewswire/ — CRG, a premier healthcare-focused investment firm, today announced three firm-wide promotions, naming Scott Li as Managing Director, and appointing Zain Shekhani and Kevin Reilly as Vice President, effective immediately.
“We congratulate this high performing group of individuals and recognize their significant contributions to CRG’s ongoing success,” said Nate Hukill, Managing Partner and Chairman of CRG. “These promotions highlight our deep bench of world-class investing talent, enable our continued growth, and will help us efficiently deploy growth capital to more healthcare companies while generating strong risk-adjusted returns for our institutional partners.”
Mr. Li joined the firm in 2015 and has helped expand the firm’s investment activities in healthcare services and healthcare information technology. Luke Duster, Partner of CRG added, “In only three years with the firm, Scott has become a key contributor to our growth strategy and expanded our investment universe to new sectors, including telemedicine, behavioral health and technology enabled services. Kevin and Zain both joined CRG early in their careers and have emerged as two of our most impactful healthcare investors.”
CRG is a premier healthcare investment firm that has committed more than $3 billion of assets across three funds to date. The firm seeks to invest between $20 to $300 million in companies across the healthcare spectrum, including: medical devices, biopharmaceuticals, tools & diagnostics, services and information technology. CRG provides growth capital in the form of long-term debt and equity to support innovative, commercial-stage healthcare companies that address large, unmet medical needs. The firm partners with public and private companies to provide flexible financing solutions and world-class support to achieve exceptional growth objectives with minimal dilution. For more information, please visit www.crglp.com.